MULLEN JAMES C 4
4 · Editas Medicine, Inc. · Filed Apr 18, 2022
Insider Transaction Report
Form 4
MULLEN JAMES C
Director
Transactions
- Award
Stock Option (right to buy)
2022-04-14+170,989→ 170,989 totalExercise: $45.69Exp: 2031-03-01→ Common Stock (170,989 underlying)
Footnotes (1)
- [F1]Reflects the vesting, upon the satisfaction of the performance criteria, of a portion of a performance-based stock option originally granted on March 2, 2021.